{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:58:33Z","timestamp":1768535913174,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"am","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["DP150074"],"award-info":[{"award-number":["DP150074"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["AP39"],"award-info":[{"award-number":["AP39"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["GYY4137"],"award-info":[{"award-number":["GYY4137"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000737","name":"University of Exeter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA175803"],"award-info":[{"award-number":["R01 CA175803"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bcp.2017.10.011","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T16:05:24Z","timestamp":1508774724000},"page":"186-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"special_numbering":"C","title":["Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation"],"prefix":"10.1016","volume":"149","author":[{"given":"Gabor","family":"Ol\u00e1h","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"M\u00f3dis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"T\u00f6r\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Szczesny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2017.10.011_b0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2017.10.011_b0010","doi-asserted-by":"crossref","first-page":"36125","DOI":"10.1038\/srep36125","article-title":"Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics","volume":"6","author":"Szczesny","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2017.10.011_b0015","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1096\/fj.12-216507","article-title":"Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics","volume":"27","author":"M\u00f3dis","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2017.10.011_b0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2119\/molmed.2016.00102","article-title":"Cystathionine-\u03b2-synthase inhibition for colon cancer: enhancement of the efficacy of aminooxyacetic acid via the prodrug approach","volume":"22","author":"Chao","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.bcp.2017.10.011_b0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0006-2952(95)02099-3","article-title":"Selective pharmacological inhibition of distinct nitric oxide synthase isoforms","volume":"51","author":"Southan","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.011_b0030","doi-asserted-by":"crossref","first-page":"318087","DOI":"10.1155\/2012\/318087","article-title":"Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges","volume":"2012","author":"V\u00edte\u010dek","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bcp.2017.10.011_b0035","doi-asserted-by":"crossref","first-page":"PL131","DOI":"10.1016\/0024-3205(95)02046-L","article-title":"7-Nitro indazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase","volume":"57","author":"Bland-Ward","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2017.10.011_b0040","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.2174\/0929867311320300003","article-title":"A focus on heme oxygenase-1 (HO-1) inhibitors","volume":"20","author":"Pittal\u00e0","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2017.10.011_b0045","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-\u03b2-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2017.10.011_b0050","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/bph.12171","article-title":"Selectivity of commonly used pharmacological inhibitors for cystathionine \u03b2 synthase (CBS) and cystathionine \u03b3 lyase (CSE)","volume":"169","author":"Asimakopoulou","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.011_b0055","doi-asserted-by":"crossref","DOI":"10.1124\/pr.117.014050","article-title":"International Union of Basic and Clinical Pharmacology. CII. Pharmacological modulation of hydrogen sulfide (H2S) levels: H2S donors and H2S biosynthesis inhibitors","author":"Szabo","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2017.10.011_b0060","doi-asserted-by":"crossref","first-page":"40227","DOI":"10.1038\/srep40227","article-title":"Discovery and mechanistic characterization of selective inhibitors of H2S-producing enzyme: 3-mercaptopyruvate sulfurtransferase (3MST) targeting active-site cysteine persulfide","volume":"7","author":"Hanaoka","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2017.10.011_b0065","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00005344-199504000-00023","article-title":"Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro","volume":"25","author":"Mooradian","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.011_b0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev.pharmtox.43.100901.135831","article-title":"Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates","volume":"43","author":"Keefer","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2017.10.011_b0075","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/01.RES.0000084381.86567.08","article-title":"Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule","volume":"93","author":"Clark","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2017.10.011_b0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrd3228","article-title":"The therapeutic potential of carbon monoxide","volume":"9","author":"Motterlini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2017.10.011_b0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.niox.2014.04.008","article-title":"AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro","volume":"41","author":"Szczesny","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2017.10.011_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2407-8-197","article-title":"Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice","volume":"8","author":"Nowis","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2017.10.011_b0095","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.bcp.2013.03.011","article-title":"Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: the involvement of the Wnt\/\u03b2-catenin signaling pathway","volume":"85","author":"Wang","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.011_b0100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/ars.2014.5933","article-title":"The therapeutic potential of cystathionine \u03b2-synthetase\/hydrogen sulfide inhibition in cancer","volume":"22","author":"Hellmich","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2017.10.011_b0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12013-011-9287-0","article-title":"USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a\/ARF pathway and Akt pathway","volume":"62","author":"Liu","year":"2012","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bcp.2017.10.011_b0110","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.febslet.2014.03.047","article-title":"Phosphorylation and changes in the distribution of nucleolin promote tumor metastasis via the PI3K\/Akt pathway in colorectal carcinoma","volume":"588","author":"Wu","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2017.10.011_b0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1471-2407-10-287","article-title":"Characterization of Akt independent effects of the synthetic Akt inhibitors SH-5 and SH-6 using an integrated approach combining transcriptomic profiling and signaling pathway perturbations","volume":"10","author":"Krech","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2017.10.011_b0120","doi-asserted-by":"crossref","first-page":"36842","DOI":"10.18632\/oncotarget.9209","article-title":"Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2017.10.011_b0125","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.3892\/or.2016.4691","article-title":"Hydrogen sulfide promotes cell proliferation of oral cancer through activation of the COX2\/AKT\/ERK1\/2 axis","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2017.10.011_b0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12943-017-0629-4","article-title":"Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK\/Elk-1\/Snail and AKT\/GSK3\u03b2\/\u03b2-catenin pathways","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2017.10.011_b0135","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/13543784.10.6.1085","article-title":"Phosphoinositide 3-kinase inhibition in cancer treatment","volume":"10","author":"Berrie","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bcp.2017.10.011_b0140","doi-asserted-by":"crossref","first-page":"18623","DOI":"10.1074\/jbc.273.29.18623","article-title":"Identification of a novel inhibitor of mitogen-activated protein kinase kinase","volume":"273","author":"Favata","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2017.10.011_b0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0026-895X(25)10233-2","article-title":"Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one","volume":"48","author":"Garthwaite","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.011_b0150","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1073\/pnas.1202916109","article-title":"Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation","volume":"109","author":"Coletta","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2017.10.011_b0155","doi-asserted-by":"crossref","first-page":"7075682","DOI":"10.1155\/2016\/7075682","article-title":"Vasorelaxant effect of a new hydrogen sulfide-nitric oxide conjugated donor in isolated rat aortic rings through cGMP pathway","volume":"2016","author":"Wu","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bcp.2017.10.011_b0160","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-16-3480","article-title":"Cystathionine-\u03b2-synthase upregulation induces metabolic reprograming and promotes colon carcinogenesis","author":"Phillips","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2017.10.011_b0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/PL00008208","article-title":"Increased in situ expression of nitric oxide synthase in human colorectal cancer","volume":"436","author":"Yagihashi","year":"2000","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bcp.2017.10.011_b0170","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.acthis.2012.02.004","article-title":"The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans","volume":"114","author":"Gochman","year":"2012","journal-title":"Acta Histochem."},{"key":"10.1016\/j.bcp.2017.10.011_b0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13058-015-0527-x","article-title":"Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer","volume":"17","author":"Granados-Principal","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bcp.2017.10.011_b0180","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1089\/ars.2016.6835","article-title":"NOS2 as an Emergent Player in Progression of Cancer","volume":"26","author":"Thomas","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2017.10.011_b0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.niox.2008.04.009","article-title":"Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis","volume":"19","author":"Grimm","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2017.10.011_b0190","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2559.2001.01189.x","article-title":"Expression of nitric oxide synthase isoforms and nitrotyrosine immunoreactivity by B-cell non-Hodgkin's lymphomas and multiple myeloma","volume":"39","author":"Mendes","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.bcp.2017.10.011_b0195","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00345-012-0878-1","article-title":"The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma","volume":"31","author":"C\u00e1ssio Zequi","year":"2013","journal-title":"World J. Urol."},{"key":"10.1016\/j.bcp.2017.10.011_b0200","first-page":"949","article-title":"Nitric oxide synthases in Kaposi's sarcoma are expressed predominantly by vessels and tissue macrophages","volume":"78","author":"Weninger","year":"1998","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bcp.2017.10.011_b0205","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/00365520701192383","article-title":"Colonic expression of heme oxygenase-1 is associated with a better long-term survival in patients with colorectal cancer","volume":"42","author":"Becker","year":"2007","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bcp.2017.10.011_b0210","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s13277-012-0336-0","article-title":"Involvement of heme oxygenase-1 in Korean colon cancer","volume":"33","author":"Kang","year":"2012","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bcp.2017.10.011_b0215","first-page":"260","article-title":"The expression of heme oxygenase-1 in human-derived cancer cell lines","volume":"36","author":"Bahmani","year":"2011","journal-title":"Iran J. Med. Sci."},{"key":"10.1016\/j.bcp.2017.10.011_b0220","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.imbio.2013.09.003","article-title":"The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes","volume":"219","author":"Duechler","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.bcp.2017.10.011_b0225","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2174\/1389450111009011551","article-title":"Heme oxygenase-1 in tumor biology and therapy","volume":"11","author":"Was","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bcp.2017.10.011_b0230","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1568009614666140320111306","article-title":"The expression, function and targeting of haem oxygenase-1 in cancer","volume":"14","author":"Hjorts\u00f8","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bcp.2017.10.011_b0235","doi-asserted-by":"crossref","first-page":"e79167","DOI":"10.1371\/journal.pone.0079167","article-title":"Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance","volume":"8","author":"Bhattacharyya","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2017.10.011_b0240","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.3892\/or.2017.5513","article-title":"Role of the cystathionine \u03b2-synthase\/H2S system in liver cancer cells and the inhibitory effect of quinolone-indolone conjugate QIC2 on the system","volume":"37","author":"Jia","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2017.10.011_b0245","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1074\/jbc.M113.507533","article-title":"NO binds human cystathionine \u03b2-synthase quickly and tightly","volume":"289","author":"Vicente","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2017.10.011_b0250","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1021\/bi4004556","article-title":"Kinetics of reversible reductive carbonylation of heme in human cystathionine \u03b2-synthase","volume":"52","author":"Carballal","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2017.10.011_b0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.freeradbiomed.2006.03.021","article-title":"Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide","volume":"41","author":"Oh","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2017.10.011_b0260","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tox.2007.08.087","article-title":"Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase","volume":"241","author":"Kubo","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2017.10.011_b0265","doi-asserted-by":"crossref","first-page":"R1608","DOI":"10.1152\/ajpregu.00207.2006","article-title":"Hydrogen sulfide downregulates the aortic l-arginine\/nitric oxide pathway in rats","volume":"293","author":"Geng","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bcp.2017.10.011_b0270","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1152\/ajpcell.00282.2016","article-title":"Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications","volume":"312","author":"Szabo","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217306421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217306421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:00:28Z","timestamp":1757768428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295217306421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":54,"alternative-id":["S0006295217306421"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.10.011","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}